行情

TYME

TYME

Tyme科技
NASDAQ

实时行情|Nasdaq Last Sale

1.045
+0.005
+0.48%
盘后: 1.000 -0.045 -4.31% 17:54 11/15 EST
开盘
1.060
昨收
1.040
最高
1.095
最低
1.000
成交量
40.54万
成交额
--
52周最高
4.642
52周最低
0.9200
市值
1.17亿
市盈率(TTM)
-3.8776
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

TYME 新闻

  • 瑞幸大涨25%录得历史新高 创上市以来最大单日涨幅
  • 新浪美股.4小时前
  • 欧股收高结束两连跌 整周录得连续第六周上涨
  • 新浪美股.4小时前
  • 收盘:美股再创新高 道指首次跨越28000点里程碑
  • 新浪美股.5小时前
  • 周五美油期货收高1.7% 布油上涨1.6%
  • 新浪美股.5小时前

更多

所属板块

生物技术和医学研究
+1.35%
制药与医学研究
+1.27%

热门股票

名称
价格
涨跌幅

TYME 简况

Tyme Technologies, Inc. is a clinical-stage biotechnology company. The Company is focused on developing cancer therapeutics that is intended to be broadly effective across tumor types and have low toxicity profiles. The Company’s therapeutic approach is designed to take advantage of a cancer cell’s innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body’s natural immune system. The Company’s lead clinical program, SM-88, is a first-in-class combination therapy in Phase II development for prostate cancer, and it is preparing to initiate an additional Phase II clinical trial for pancreatic cancer. The Company provides a novel compound for physicians to use in a treatment regimen for patients fighting six major cancers including breast, lung, prostate, gastric, esophageal and pancreatic cancers.
展开

Webull提供Tyme Technologies Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。